BioSpace News Archive

Policy

Health Canada approves additional indication for NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) in combination with docetaxel

Bayer Inc. announced that Health Canada, following a priority review, has approved NUBEQA® for the treatment of patients with metastatic castration-sensitive prostate cancer in combination with docetaxel1.

October 5, 2022
·
9 min read
DEINOVE to present data on DNV3837 at the ESCMID/ASM conference in Dublin

DEINOVE announces that a poster titled « DNV3837, a parenteral GI tract-targeted treatment for Clostridioides difficile infection » is to be presented at the ESCMID/ASM conference taking place in Dublin, from October 4 to 7.

October 5, 2022
·
6 min read
Biotech Beach

Certis Oncology Releases New Cancer Model Database, BarneyOI™

Certis Oncology Solutions, a life science technology company, announced today the release of its new cancer model database, BarneyOI™.

October 5, 2022
·
2 min read
Business

Lycia Therapeutics Founder Dr. Carolyn Bertozzi Awarded 2022 Nobel Prize in Chemistry

Lycia Therapeutics, Inc. announced that founder Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in Chemistry.

October 5, 2022
·
2 min read
Business

Venus Concept Announces Updated Release Date of November 10, 2022 for Third Quarter of Fiscal Year 2022 Financial Results

Venus Concept Inc. announced today that it is updating the release date for its third quarter of fiscal year 2022 financial results.

October 5, 2022
·
1 min read
Business

Assembly Bio Announces Retirement of John G. McHutchison, AO, MD as CEO and Appoints Current President and COO Jason A. Okazaki as Successor

Assembly Biosciences, Inc. today announced that John G. McHutchison, AO, MD, chief executive officer (CEO), will retire as CEO at the end of 2022.

October 5, 2022
·
8 min read
Genetown

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 05, 2022

Syros Pharmaceuticals announced the grant of a restricted stock unit award for 1,260 shares of Syros common stock to one newly hired employee in connection with the employee’s commencement of employment with Syros.

October 5, 2022
·
1 min read
Bio NC

Shattuck Labs to Present Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting November 8-12

Shattuck Labs, Inc. today announced it will present a poster on its bispecific Gamma Delta T Cell Engager (GADLEN) platform at SITC’s 37th Annual Meeting being held November 8th – 12th, 2022.

October 5, 2022
·
2 min read
Business

Conformis, Inc. to Announce Financial Results for Its Third Quarter 2022

Conformis, Inc. announced today it will release its financial results for the third quarter ended September 30, 2022, after the market closes on Wednesday, November 2, 2022.

October 5, 2022
·
1 min read
Pharm Country

Cellectis to Present Pre-Clinical Data on TALEN®-edited Smart CAR T-cells Supporting Improved Solid Tumor Targeting at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

Cellectis announced today that pre-clinical data on TALEN ® -edited smart CAR T-cells to overcome key challenges of targeting solid tumors, will be presented at the Society for Immunotherapy of Cancer’s 37th Annual Meeting (SITC 2022), to be held in Boston, M.A.

October 5, 2022
·
4 min read